Andre Goy, MD, chief of the lymphoma division at Hackensack University’s John Theurer Cancer Center, will co-chair the upcoming 21st Annual International Congress on Hematologic Malignancies along with Emory University’s Sager Lonial.
This marks the third time Goy is co-chairing the event, which takes place February 23-25 at Trump International Beach Resort in Sunny Isles Beach, Florida. The congress includes Medical Crossfire discussion panels, which give oncologists and other healthcare professionals a chance to learn from and engage with national experts to increase their clinical knowledge, apply new data and improve patient outcomes.
Anyone interested in the treatment of hematologic malignancies, including community-based hematologists, medical oncologists, fellows working with hematologic malignancies, nurses and nurse practitioners, physician assistants, pharmacists, researchers and others, may participate.
At the end of the three-day congress, attendees should be better prepared to discuss current genomic and molecular biomarkers that are used to inform decision-making in the management of these malignancies; assess trial results and their impact; delineate strategies to mitigate and manage predictable side effects; evaluate recent findings concerning novel compounds or approaches, and consider the therapeutic implications of emerging data on current treatment paradigms for these malignancies.
Among other things, Goy was instrumental in developing John Theurer Cancer Center’s Tissue Bank, which stores and analyzes samples of cells, tissue and other anatomical structures for research purposes. The Tumor Bank has received more than 1,600 patient consents since it opened.
“I am honored and energized to once again chair the 21st Annual Hematology Conference, which brings together leading experts from around the world,” Goy said in a press release. “Our Hematology Conference in Miami provides a forum for oncologists to meet experts, discuss cases and review the rapid changes happening in the field, and in particular, appreciate what becomes relevant as new standards.”
The congress encourages collaborative initiatives among healthcare experts on treatment options. Besides the John Theurer Cancer Center, other participating institutions include Memorial Sloan Kettering Cancer Center, Georgetown University, Paris University Hospital System, Emory University and Mayo Clinic.
